Business Context and Reporting Period
This Form 8-K was filed by BioXcel Therapeutics, Inc. (BTAI) on August 24, 2026, reporting events occurring on August 21, 2026. The filing addresses a material definitive agreement regarding the company's existing credit facilities.
Key Financial Metrics
The filing does not provide specific numerical values for revenue, profit, cash flow, margins, or total debt. The document focuses exclusively on the terms of a credit agreement amendment rather than periodic financial performance.
Material Changes
- Credit Agreement Amendment: The Company entered into the Thirteenth Amendment to its Credit Agreement and Guaranty (originally dated April 19, 2022).
- Repayment Deadline Extension: The deadline to resolve outstanding loan obligations was extended from August 21, 2026, to August 28, 2026.
- Required Actions: The Company must enter into definitive agreements by the new deadline for either:
- Repayment of all loan and other obligations under the Credit Agreement; or
- An alternative capital solutions transaction acceptable to the Lenders.
Outlook, Risks, and Contingencies
The filing highlights a critical liquidity contingency. The Company faces an immediate requirement to secure either full repayment of its debt or an alternative capital solution by August 28, 2026. Failure to meet this condition could result in default under the Credit Agreement. No forward-looking guidance regarding product development or revenue projections is included in this specific report.
Investor Verification Checklist
- Verify the Company's ability to secure a capital solution or repayment source by the August 28, 2026 deadline.
- Review the full text of the Thirteenth Amendment (Exhibit 10.1) for specific covenants or conditions attached to the extension.
- Monitor subsequent filings for confirmation of the transaction type (repayment vs. alternative capital) and its impact on the capital structure.
- Assess the Company's current cash position relative to the total outstanding obligations under the Credit Agreement.